BioSpace News Archive

Business

Vanda Pharma Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance

Vanda Pharma today announced preliminary unaudited financial results for the fourth quarter and full year 2017 and its financial guidance for 2018.

January 7, 2018
·
7 min read
Business

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

Harbour Biomed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human therapeutic monoclonal antibodies to BeiGene

January 7, 2018
·
2 min read
F1 Oncology Announces Development Milestone and $10M Equity Investment

The two conditionally active CAR-T cellular products targeting AXL and ROR2 will be tested in subjects with refractory, advanced stage mRCC.

January 7, 2018
·
3 min read
Business

F1 Oncology’s International Affiliates and Sinobioway Sunterra Biotech Announce New Development, Manufacturing, and Supply Agreements to Support cGMP Lentivirus Supply

The new facility, Shenzhen Biowit, which will expand from the current clinical production staff and site in Shenzhen, is scheduled for completion in 2018 and will utilize F1 Oncology’s chemically defined suspension-based lentivirus manufacturing technology and processes.

January 7, 2018
·
4 min read
Business

ReWalk Robotics Appoints Ori Gon as CFO

The current CFO is leaving to pursue an outside opportunity after putting in place and executing on ReWalk’s business strategies in collaboration with the Company’s board and management team.

January 7, 2018
·
5 min read
Deals

Celularity Scoops Up Alliqua BioMedical in $29M Deal

Alliqua BioMedical’s Board of Directors unanimously approved entering into the agreement.

January 7, 2018
·
6 min read
Drug Development

Akcea Initiates Phase IIb Study of AKCEA-APOCIII-LRx in Patients With Hypertriglyceridemia and Established Cardiovascular Disease

The study will evaluate the safety and efficacy of different doses and dosing frequencies of AKCEA-APOCIII-LRx in this patient population and provide valuable information for a potential Phase 3 cardiovascular outcomes study.

January 7, 2018
·
7 min read
BioMidwest

Skyline Medical Announces Pricing of Firm Commitment Public Offering of Common Stock and Warrants

Dawson James Securities, Inc. is acting as the sole underwriter for the offering.

January 7, 2018
·
6 min read
Business

Ally Bridge Group and LifeTech Scientific Form China-Global Medtech Investment and Operating Partnership

The ABG-LifeTech partnership encompasses three key components.

January 7, 2018
·
3 min read
Business

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2017 Sales Results and 2018 Program Milestones

Neurocrine Biosciences today announced an update on its business performance, including preliminary sales results for 2017 and key program initiatives for 2018.

January 7, 2018
·
8 min read